Nursing care
NPH Insulin: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
NPH insulin is an intermediate-acting, cloudy insulin that must be gently rolled, never shaken, before drawing up. It peaks 4 to 12 hours after administration, which is why patients who skip lunch after a morning dose are at real risk of afternoon hypoglycaemia. Nursing care centres on timing doses with meals and recognising that peak window.
Why this drug and not another
NPH, or neutral protamine Hagedorn, is an intermediate-acting insulin used to provide basal coverage between meals and overnight, filling the gap that rapid-acting insulins cannot cover on their own. It is often chosen over long-acting analogues such as glargine for cost reasons, since NPH remains significantly cheaper and is still widely used, particularly outside well-resourced settings.
Its onset of roughly 1 to 2 hours and duration of 12 to 18 hours make it suitable for twice-daily dosing regimens, commonly given before breakfast and before the evening meal or at bedtime. It is frequently combined with a short- or rapid-acting insulin in the same regimen, or premixed with regular insulin, to cover both basal and mealtime needs.
Administration and timing
NPH is cloudy in appearance because protamine and zinc are added to delay absorption, unlike the clear solutions of rapid- and long-acting insulins. Before drawing up or injecting, the vial or pen must be gently rolled between the palms, never shaken, to resuspend the particles evenly without introducing air bubbles or damaging the insulin protein structure.
Give it subcutaneously at the same times each day relative to meals, since consistency is what keeps the peak predictable. When mixing NPH with regular insulin in the same syringe, draw the regular insulin first to avoid contaminating its vial with the cloudy NPH. Rotate injection sites within the same general area to reduce variability in absorption.
Monitoring parameters
Blood glucose monitoring should be timed around the known pharmacokinetics: check before each dose, and be alert around the 4 to 12 hour peak window, which for a morning dose typically falls in the early to mid afternoon. A patient who has a normal breakfast-time glucose but skips or delays lunch is walking directly into that peak with no carbohydrate on board.
Track patterns over days rather than reacting to a single reading, since NPH's variable absorption means glucose response can shift day to day even with consistent dosing. Ask specifically about meal timing when reviewing glucose logs, because a low reading in the early afternoon after a morning dose is rarely coincidental.
Adverse effects to report
Hypoglycaemia is the adverse effect that matters most, and with NPH it clusters predictably around the peak window rather than appearing at random. Watch for diaphoresis, tremor, confusion, tachycardia, and hunger, and treat promptly with fast-acting carbohydrate followed by a longer-acting source once the patient can safely swallow.
Lipodystrophy, either lipohypertrophy or lipoatrophy, can develop at injection sites with repeated use in the same spot, and it affects absorption unpredictably, so site rotation is not just cosmetic advice. Report any unexplained pattern of hypoglycaemia or hyperglycaemia, since it may reflect site rotation issues, missed meals, or a need to adjust the dose rather than a one-off event.
Contraindications and cautions
NPH is contraindicated during episodes of hypoglycaemia and requires caution in patients with erratic eating patterns, since a missed or delayed meal after dosing directly sets up a peak-time low. Renal or hepatic impairment can prolong insulin clearance and increase hypoglycaemia risk, so doses may need adjustment and monitoring intensified.
Use caution in patients with limited ability to recognise or report hypoglycaemia symptoms, including those with cognitive impairment, autonomic neuropathy, or on beta-blockers that can mask the adrenergic warning signs. Illness, vomiting, or reduced oral intake all warrant closer monitoring rather than automatic dose withholding, since insulin needs may actually rise during acute illness even as intake falls.
Teaching points the exam tests
Exam questions repeatedly test three things about NPH: that it is cloudy and must be rolled rather than shaken, that its peak of 4 to 12 hours creates a specific hypoglycaemia risk window, and that when mixed with regular insulin the regular is drawn up first. Expect scenario questions describing a patient who skipped lunch after a morning NPH dose and now presents with sweating and confusion mid-afternoon.
Teaching a patient before discharge should cover eating a meal or snack timed to the expected peak, never skipping meals after a dose, recognising and treating hypoglycaemia symptoms immediately, and storing insulin correctly, refrigerated when not in use and at room temperature once in use, discarding vials or pens per the manufacturer's timeframe after opening.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our endocrine practice questions are the closest set to what this page covers.
Common questions
Why is NPH insulin cloudy?
NPH contains protamine and zinc added to the insulin to delay its absorption and extend its action over 12 to 18 hours. This suspension makes the solution cloudy, unlike clear rapid- or long-acting insulins, and it must be resuspended by gently rolling the vial or pen before each dose.
When is NPH insulin most likely to cause hypoglycaemia?
NPH peaks 4 to 12 hours after administration, so a morning dose creates its highest hypoglycaemia risk in the early to mid afternoon. Patients who delay or skip a meal during that window are at particular risk and should be taught to eat consistently after each dose.
Can NPH and regular insulin be mixed in the same syringe?
Yes, and this is a common combination to cover both basal and mealtime needs in one injection. The regular insulin must be drawn into the syringe first, followed by the NPH, to prevent the cloudy NPH suspension from contaminating the clear regular insulin vial.
Why roll NPH insulin instead of shaking it?
Shaking creates air bubbles and can damage the insulin protein structure, leading to inaccurate dosing and reduced effectiveness. Gently rolling the vial or pen between the palms resuspends the protamine and zinc particles evenly without that risk.